Back
ProQR Therapeutics NV Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
PRQR
ProQR Therapeutics NV
Last Price:
1.79
Seasonality Move:
-2.94%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight buying pressure.
ProQR Therapeutics NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.83 | Sell |
| 20-day SMA: | 1.92 | Sell |
| 50-day SMA: | 1.92 | Sell |
| 200-day SMA: | 2 | Sell |
| 8-day EMA: | 1.83 | Sell |
| 20-day EMA: | 1.89 | Sell |
| 50-day EMA: | 1.91 | Sell |
| 200-day EMA: | 1.91 | Sell |
ProQR Therapeutics NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 34.88 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.83 - 2.09) | Sell |
| Bollinger Bands (100): | (1.74 - 2.02) | Sell |
ProQR Therapeutics NV Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProQR Therapeutics NV Stock
Is ProQR Therapeutics NV Stock a Buy?
- ProQR Therapeutics NV share price is 1.79 while PRQR 8-day simple moving average is 1.83, which is a Sell signal.
- The stock price of PRQR is 1.79 while ProQR Therapeutics NV 20-day SMA is 1.92, which makes it a Sell.
- ProQR Therapeutics NV 50-day simple moving average is 1.92 while PRQR share price is 1.79, making it a Sell technically.
- PRQR stock price is 1.79 and ProQR Therapeutics NV 200-day simple moving average is 2.00, creating a Sell signal.
PRQR Technical Analysis vs Fundamental Analysis
Sell
27
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a Sell
The current ProQR Therapeutics NV [PRQR] share price is $1.79. The Score for PRQR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
ProQR Therapeutics NV Stock Info
Market Cap:
146.21M
Price in USD:
1.79
Share Volume:
69.31K
ProQR Therapeutics NV 52-Week Range
52-Week High:
3.29
52-Week Low:
1.11
Sell
27
ProQR Therapeutics NV (PRQR)
is a Sell
ProQR Therapeutics NV Share Price Forecast
-
What is the ProQR Therapeutics NV stock price today?
The ProQR Therapeutics NV stock price is 1.79 USD today. -
Will PRQR stock go up or go down?
ProQR Therapeutics NV> share price is forecast to RISE/FALL based on technical indicators -
Is ProQR Therapeutics NV overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProQR Therapeutics NV is overvalued.
Is ProQR Therapeutics NV Stock a Buy?
- ProQR Therapeutics NV share price is 1.79 while PRQR 8-day exponential moving average is 1.83, which is a Sell signal.
- The stock price of PRQR is 1.79 while ProQR Therapeutics NV 20-day EMA is 1.89, which makes it a Sell.
- ProQR Therapeutics NV 50-day exponential moving average is 1.91 while PRQR share price is 1.79, making it a Sell technically.
- PRQR stock price is 1.79 and ProQR Therapeutics NV 200-day simple moving average is 1.91, creating a Sell signal.
Fundamental Analysis of ProQR Therapeutics NV
Is ProQR Therapeutics NV a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
Technical Analysis of ProQR Therapeutics NV
Should I short ProQR Therapeutics NV stock?
- PRQR Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting ProQR Therapeutics NV is a Sell
- ProQR Therapeutics NV Relative Strength Index (RSI) is 34.88, which suggest ProQR Therapeutics NV is oversold
- The Bollinger Bands (25) for ProQR Therapeutics NV is (1.83 - 2.09), which suggest ProQR Therapeutics NV is a Sell
- The Bollinger Bands (100) for ProQR Therapeutics NV is (1.74 - 2.02), which suggest ProQR Therapeutics NV is a Sell
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.